Warning
Wizcure Pharmaa Private Limited Recalls Vista Tears Polyethylene Glycol 400 0.4% w/v
This is a Class II recall. This product may cause temporary health problems or pose a slight threat of a serious nature.
Source: FDA
WarningRecall #D-0346-2026Drug / Pharmaceutical
Wizcure Pharmaa Private Limited Recalls Vista Tears Polyethylene Glycol 400 0.4% w/v
Wizcure Pharmaa Private Limited · Class II — Moderate Risk
Product Description
Vista Tears Polyethylene Glycol 400 0.4% w/v, Propylene Glycol 0.3% w/v Eye Drops, Dry Eye Relief, Lubricant Drops, Sterile 10 ml (1/3 fl. oz.), Manufactured by: RA/Drugs/ MFG/2019/196283, Omni Lens Pvt. Ltd. 5, Samrudhhi, Opposite:Sakar-III, Navrangpura, Ahmedabad-380014, INDIA. Manufactured for and distributed by hi-health, 15207 N. 75th Street, Suite #104, Scottsdale, AZ, 85260. NDC 77790-001-10.
Reason for Recall
Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices.
FDA Classification
Class II — Moderate Risk
A situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Distribution
Distributed Nationwide in the USA
Remedy
Consumers should stop using this product. Contact the recalling firm for further instructions regarding this product.
411 Press Analysis
The FDA classified this recall as Class II, indicating the pharmaceutical product may cause temporary health problems or poses a slight threat of a serious nature. Wizcure Pharmaa Private Limited initiated the recall on December 31, 2025 affecting 5,760 cartons. Lack of Assurance of Sterility: Products have not been manufactured in conformance with current good manufacturing practices. The product was distributed in Distributed Nationwide in the USA. Consumers should check their purchases and discontinue use of any affected product. Contact Wizcure Pharmaa Private Limited for further instructions.
Sources: FDA openFDA Enforcement Database
This recall appears in: Drug & Medication Defects.